Five Prime Therapeutics, Inc. EBITDA Margin 2013-2020 | FPRX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Five Prime Therapeutics, Inc. (FPRX) over the last 10 years. The current EBITDA margin for Five Prime Therapeutics, Inc. as of December 31, 2020 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2020-12-31 | $0.01B | $-0.09B | -716.67% |
| 2020-09-30 | $0.02B | $-0.10B | -600.00% |
| 2020-06-30 | $0.02B | $-0.10B | -588.24% |
| 2020-03-31 | $0.02B | $-0.12B | -700.00% |
| 2019-12-31 | $0.01B | $-0.14B | -971.43% |
| 2019-09-30 | $0.02B | $-0.15B | -980.00% |
| 2019-06-30 | $0.02B | $-0.16B | -883.33% |
| 2019-03-31 | $0.02B | $-0.16B | -691.30% |
| 2018-12-31 | $0.05B | $-0.14B | -286.00% |
| 2018-09-30 | $0.06B | $-0.13B | -223.73% |
| 2018-06-30 | $0.06B | $-0.13B | -208.20% |
| 2018-03-31 | $0.06B | $-0.13B | -219.67% |
| 2017-12-31 | $0.04B | $-0.15B | -376.92% |
| 2017-09-30 | $0.03B | $-0.15B | -435.29% |
| 2017-06-30 | $0.03B | $-0.13B | -393.94% |
| 2017-03-31 | $0.03B | $-0.11B | -314.71% |
| 2016-12-31 | $0.03B | $-0.09B | -300.00% |
| 2016-09-30 | $0.39B | $0.27B | 70.47% |
| 2016-06-30 | $0.39B | $0.27B | 71.17% |
| 2016-03-31 | $0.38B | $0.28B | 73.82% |
| 2015-12-31 | $0.38B | $0.29B | 76.78% |
| 2015-09-30 | $0.02B | $-0.06B | -261.90% |
| 2015-06-30 | $0.02B | $-0.04B | -180.95% |
| 2015-03-31 | $0.02B | $-0.04B | -180.00% |
| 2014-12-31 | $0.02B | $-0.03B | -170.00% |
| 2014-09-30 | $0.02B | $-0.03B | -157.89% |
| 2014-06-30 | $0.02B | $-0.03B | -193.75% |
| 2014-03-31 | $0.02B | $-0.03B | -193.33% |
| 2013-12-31 | $0.01B | $-0.03B | -200.00% |
| 2013-09-30 | $0.01B | $-0.03B | -207.69% |
